Change in Boardroom
04/02/2020Change in Boardroom
Amended Announcements
Please refer to the earlier announcement reference number: C03-30052019-00007
SUNZEN BIOTECH BERHAD |
Date of change | 30 May 2019 |
Name | DR FONG CHAN SENG |
Age | 72 |
Gender | Male |
Nationality | Malaysia |
Designation | Independent Director |
Directorate | Independent and Non Executive |
Type of change | Appointment |
Qualifications
No | Qualifications |
Major/Field of Study |
Institute/University |
Additional Information |
Degree
|
Veterinary Science and Animal Husbandry |
Bombay Veterinary College, India |
|
Working experience and occupation | Dr Fong has thirty seven (37) years of industry experience. He held several job portfolios during his employment with Pfizer - Malaysia. Dr Fong joined Pfizer as Veterinary Promotions Manager in 1981. Throughout seven (7) years of serving the domestic market in Malaysia, he held positions as Product Manager, National Sales Manager and Feedmill Marketing Manager. Dr Fong was posted to Thailand as the Business Manager of Pfizer Thailand Ltd for three (3) years from 1988 to 1990. His responsibilities included running the animal health business of Pfizer Thailand, and a premix plant, product formulation, product quality control, and development of product stability. He was promoted to the position of Regional Director of Sales for Association of South East Asia Nation (ASEAN) countries in 1991. He was also in charge of business development for Pfizer in China, Hong Kong and Sri Lanka. When Pfizer acquired the worldwide animal health business of SmithKline Beecham, he was specifically in charge of the acquisition and problem solving activities in the Philippines from 1994 to 1996. In 1998, Dr Fong together with the existing management of Pfizer in Malaysia, established Sunzen Corporation Sdn. Bhd. ("Sunzen Corporation") to undertake a management buy-out of Pfizers local distribution and marketing operations. In 2001, Dr Fong left Sunzen Corporation to join Phibro Animal Health Inc, USA as Regional Director for ASEAN countries and as Managing Director of their local incorporated company, Phibro Malaysia Sdn Bhd. He rejoined Sunzen Corporation in 2002 and appointed as an Executive Director of Sunzen Biotech Berhad on 25 April 2008 and subsequently resigned on 18 July 2014. |
Directorships in public companies and listed issuers (if any) | Nil |
Family relationship with any director and/or major shareholder of the listed issuer | Nil |
Any conflict of interests that he/she has with the listed issuer | Nil |
Details of any interest in the securities of the listed issuer or its subsidiaries | Direct - 31,290 Ordinary Shares in the Company |
Remarks : |
The direct interest of Dr Fong Chan Seng in the Company should be 31,290 ordinary shares instead of 30,000 ordinary shares. |
Announcement Info
Company Name | SUNZEN BIOTECH BERHAD |
Stock Name | SUNZEN |
Date Announced | 04 Feb 2020 |
Category | Change in Boardroom |
Reference Number | C03-14012020-00006 |
Related Announcements for SUNZEN
Date | Title |
---|---|
25/02/2022 | Change in Boardroom |
01/10/2020 | Change in Boardroom |
30/07/2020 | Change in Boardroom |
30/07/2020 | Change in Boardroom |
16/06/2020 | Change in Boardroom |
16/06/2020 | Change in Boardroom |
30/05/2019 | Change in Boardroom |
14/05/2019 | Change in Boardroom |
30/11/2018 | Change in Boardroom |
09/11/2018 | Change in Boardroom |